Building New Models To Support The Ailing Antibiotics Market

photocredit: Getty The battle against antimicrobial resistance has reached an inflection point. As a nation, we have implemented groundbreaking legislation, invigorated research initiatives, demonstrated strong leadership in innovative regulatory frameworks, and fostered improvements in clinical practice. Yet, despite these best efforts, challenges sustaining a robust enterprise to address the growing threat […]

Read the full post on Forbes - Healthcare